Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose finding study of TAK-438 in patients with reflux esophagitis (phase II)
jRCT2080220896Phase 2
- Sponsor
- Takeda
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vonoprazan in erosive esophagitis (EE) and gastroesophageal reflux disease (GERD) (3 arms), sponsored by Takeda.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on jRCT2080220896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220896.